The HSV-1 and HVP-2 titers were determined by the inoculation of test solutions into Vero cell cultures and calculated using the Reed M?ench method.
Andrés Tamayo
Advertisement
Articles by Andrés Tamayo
Development guidelines for MAbs serve as a blueprint for their manufacture, safety, and efficacy testing.
Advertisement
Latest Updated Articles
GMP Compliance for Production of CB.Hep-1 Monoclonal Antibody as a Biological ReagentPublished: February 1st 2006 | Updated:
Downstream Processing: A Revalidation Study of Viral Clearance in the Purification of Monoclonal Antibody CB.Hep-1Published: January 1st 2007 | Updated:
Advertisement
Advertisement
Trending on BioPharm International
1
Why Flexibility and Commercial Viability Must Be Built-in Early for Scaling CGTs
2
How Rentschler Biopharma’s New Platforms Aim to Accelerate Biologics Development in Asia
3
Analyzing the Safety and Scope of Next-Generation Gene Editing Platforms
4
